U.S., July 4 -- ClinicalTrials.gov registry received information related to the study (NCT07050446) titled 'Vizol S DIGI EYE Efficacy and Safety Study in Patients With Dry Eye' on June 24.
Brief Summary: The clinical investigation was intended to investigate the efficacy, ocular tolerability and safety of Vizol S DIGI EYE, a new eye drops, solution developed by JADRAN - GALENSKI LABORATORIJ d.d., in patients with moderate to severe evaporative DED after a treatment for 28 days.
Study Start Date: March 20, 2024
Study Type: INTERVENTIONAL
Condition:
Dry Eye Disease (DED)
Intervention:
DRUG: Vizol S DIGI EYE eye drops
1 drop 4 times a day
DRUG: 0,9% saline solution, eye drops
1 drop 4 times a day
Recruitment Status: COMPLETED
Spons...